Detalhe da pesquisa
1.
Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis.
Brain Behav Immun
; 113: 136-144, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37437819
2.
Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder.
Compr Psychiatry
; 68: 34-9, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27234180
3.
Identification of a biological signature for schizophrenia in serum.
Mol Psychiatry
; 17(5): 494-502, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21483431
4.
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.
Mol Psychiatry
; 16(8): 848-59, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20585325
5.
Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.
Mol Psychiatry
; 15(11): 1088-100, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19546861
6.
Differential effects on T-cell function following exposure to serum from schizophrenia smokers.
Mol Psychiatry
; 15(4): 364-71, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19002140
7.
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.
Mol Psychiatry
; 18(1): 10-1, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22349781
8.
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Mol Psychiatry
; 13(12): 1118-28, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17938634
9.
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.
Transl Psychiatry
; 7(8): e1186, 2017 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28763062
10.
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.
Mol Psychiatry
; 15(2): 118-9, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20098438
11.
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.
Front Pharmacol
; 7: 422, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27877130
12.
Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings.
Pharmacopsychiatry
; 43(5): 196-7, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20191444
13.
Serum proteomic profiling of major depressive disorder.
Transl Psychiatry
; 5: e599, 2015 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26171980
14.
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.
Transl Psychiatry
; 5: e601, 2015 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26171982
15.
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.
Psychopharmacology (Berl)
; 142(3): 230-5, 1999 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-10208314
16.
Reduced binocular depth inversion in schizophrenic patients.
Schizophr Res
; 53(1-2): 101-8, 2002 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11728843
17.
Elevated endogenous cannabinoids in schizophrenia.
Neuroreport
; 10(8): 1665-9, 1999 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-10501554
18.
Impaired binocular depth inversion in patients with alcohol withdrawal.
J Psychiatr Res
; 30(6): 469-74, 1996.
Artigo
Inglês
| MEDLINE | ID: mdl-9023790
19.
Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices.
Epilepsy Res
; 6(3): 187-98, 1990 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-2272342
20.
Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse.
Int Clin Psychopharmacol
; 14(1): 37-9, 1999 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-10221641